News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
148 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Deals
Novan Acquires IP Rights to Treat Viral Malignancies With Nitric Oxide
Novan completed a transaction with KNOW Bio, LLC granting Novan exclusive worldwide rights for certain oncovirus applications of nitric oxide-based products.
October 18, 2017
·
8 min read
Business
Edge Therapeutics Announces Third Quarter Financial Results Conference Call on November 1, 2017
The conference call will be available via phone and webcast.
October 18, 2017
·
2 min read
Policy
Myriad’s BRACAnalysis CDx Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Lynparza (olaparib) in Metastatic Breast Cancer
The company expects fda priority review to conclude in the fiscal third-quarter 2018.
October 18, 2017
·
9 min read
Business
AELIX Therapeutics Appoints Dr. Thomas Hecht As Chairman Of The Board Of Directors
Aelix Therapeutics announces the appointment of Dr. Thomas Hecht as chairman of its board of directors.
October 18, 2017
·
3 min read
Drug Development
Loxo Oncology Announces Positive Top-Line Results from Independent Review Committee Assessment of Larotrectinib Dataset
The full dataset is being reserved for a future publication.
October 18, 2017
·
6 min read
Business
Dimerix Appoints Medical Advisory Board In Readiness For Phase 2b Trials
Dimerix is pleased to announce the appointment of a Medical Advisory Board (MAB) to help guide the Company’s DMX-200 clinical program.
October 18, 2017
·
8 min read
Policy
FDA Advisory Committee Scheduled to Review Lipocine’s TLANDO on January 10, 2018
The FDA has previously set February 8, 2018 as the Prescription Drug User Fee Act (“PDUFA”) goal date.
October 18, 2017
·
3 min read
Pharm Country
Researchers At The Center For Translational Cancer Research At Christiana Care Health System Discover Blood Test That May Diagnose Breast Cancer
In a potential major breakthrough in breast cancer research, scientists at the Center for Translational Cancer Research (CTCR) at the Helen F. Graham Cancer Center & Research Institute of Christiana Care Health System have developed a revolutionary new blood test to diagnose breast cancer.
October 18, 2017
·
4 min read
Business
The Foundation for Women’s Cancer and TESARO Announce 2nd Year of Partnership Supporting the National Race to End Women’s Cancer
TESARO is the Presenting Break-Through Sponsor of the 8th annual National Race to End Women’s Cancer.
October 18, 2017
·
2 min read
Business
University of Melbourne and Telix Pharmaceuticals Establish Cancer Translational Research Partnership
Novel technology discovered at University of Melbourne has the potential to transform the management of cancer.
October 18, 2017
·
5 min read
Previous
13 of 15
Next